Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available ...
Live Science on MSN

A cheap arthritis drug shows promise treating RSV in early study

An arthritis drug reduces the amount of RSV in human respiratory cells, but experts say it's too early to say if it will ...

This new drug candidate is effective against measles and other viruses, researchers say

A new drug candidate could help treat measles, croup and other related viral diseases that cause contagious and ...
Morning Overview on MSN

The FDA cleared Xocova, the first oral antiviral to prevent COVID-19 after exposure, in a five-day pill course shown to cut infections in a phase 3 trial

Households where someone tests positive for COVID-19 now have an oral drug option to protect the people around them. The FDA ...

Georgia State study highlights new antiviral drug research

Dr. Richard Plemper discusses a new oral antiviral drug candidate showing promise against orthoparamyxovirus diseases, ...
The Manila Times

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as ...
MedPage Today on MSN

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

Ensitrelvir cut household contacts' risk of developing COVID by more than half ...
The BMJ

Medical news in brief: Antiviral drug for hantavirus, patient data concerns, rules on GP harassment, and other stories

Around 1.17 billion people had a mental health condition in 2023, up from 599 million in 1990, said an analysis published in ...

US regulator approves oral drug from Japan's Shionogi to prevent COVID-19

TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...
Neurology Advisor

Oral Antiviral Xocova Approved for COVID-19 Postexposure Prophylaxis

The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.
News-Medical.Net

New AI tools identify potential drugs for rare Ebola virus

Recent advances in artificial intelligence have enabled Southwest Research Institute (SwRI) to identify nearly two dozen antiviral compounds that could potentially treat a rare species of Ebola virus ...

Chinese medical team donates antiviral medications to Sierra Leone

The 27th batch of the Chinese medical team to Sierra Leone on Friday donated a consignment of antiviral medications to Sierra Leone's Ministry of Health and Sanitation in Freetown, the country's ...